FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 108 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 7.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $12,105,000 | – | 114,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JAY JEFFREY R | 494,100 | $16,834,000 | 13.30% |
| Consonance Capital Management LP | 650,608 | $22,166,000 | 7.88% |
| Global Alpha Capital Management Ltd. | 111,246 | $3,998,000 | 3.98% |
| Breithorn Capital Management | 60,000 | $2,044,000 | 1.35% |
| Artal Group S.A. | 914,442 | $31,155,000 | 0.98% |
| Montibus Capital Management LLC | 146,446 | $4,989,415,000 | 0.63% |
| 683 Capital Management, LLC | 50,000 | $1,704,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 45,450 | $1,548,000 | 0.38% |
| Spark Investment Management LLC | 33,600 | $1,141,000 | 0.31% |
| THOMPSON SIEGEL & WALMSLEY LLC | 374,577 | $12,761,000 | 0.28% |